ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PRTC
#5777
PureTech Health plc American Depositary Shares
16.7
7
+0.72%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+0.72%
月次変化
-11.69%
6か月変化
-4.17%
1年の変化
-5.79%
以前の終値
16.6
5
Open
17.0
0
Bid
Ask
Low
16.7
7
High
17.0
0
ボリューム
2
マーケット
株
ヘルスケア
PRTC
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
TTM
Cash from operating activities
—
—
Cash from investing activities
—
—
Cash from financing activities
—
—
Free cash flow
—
—
PureTech Health plc - American Depositary Shares
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
ニュース
Deupirfenidone, nadir akciğer hastalığı için yetim ilaç statüsü aldı
Deupirfenidone receives orphan drug status for rare lung disease
PureTech’in deupirfenidone ilacı IPF için FDA ve AB’den yetim ilaç statüsü aldı
PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF
PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
PureTech CEO’su J.P. Morgan Sağlık Konferansı’nda sunum yapacak
PureTech CEO to present at J.P. Morgan Healthcare Conference
PureTech Health, Robert Lyne’ı kalıcı CEO olarak atadı
PureTech Health appoints Robert Lyne as permanent CEO
PureTech, hissedar endişelerinin ardından Genel Kurul sonuçları hakkında bilgi verdi
PureTech provides update on AGM results following shareholder concerns
PureTech hissesi, IPF ilacı hakkındaki FDA toplantısı sonrası düştü